The Ophthalmic Device Market is benefiting from continued growth in ophthalmic procedures and rapid advances in surgical technology. Market Research Future identifies surgical devices as a major component of the industry, with the segment valued at approximately USD 12.45 billion in 2025. Increasing cataract and refractive procedures, together with technological upgrades, are supporting demand for sophisticated surgical platforms.

Cataract procedures represent the largest disease-related demand category, accounting for roughly 41.5% of total spending in 2025. This reflects the large global surgical volume associated with aging populations and the continuing need to expand cataract-care capacity in both developed and emerging healthcare systems.

The surgical-device landscape includes technologies such as phacoemulsification systems, femtosecond lasers, vitrectomy platforms, and other specialized ophthalmic instruments. Innovation is increasingly centered on precision, minimally invasive techniques, visualization, and workflow efficiency.

Ambulatory surgery centers are becoming another important commercial channel. The report identifies ASCs as the fastest-growing end-user category, with an estimated 8.3% CAGR. The movement of selected ophthalmic procedures toward outpatient settings can increase demand for compact equipment, efficient workflows, and devices designed for high procedural throughput.

Future opportunities are also emerging in minimally invasive glaucoma surgery and advanced intraocular-lens technologies. As ophthalmic surgery becomes increasingly technology-intensive, manufacturers that combine surgical hardware with premium implants, software, imaging, and consumables can develop broader value propositions across the ophthalmic-care ecosystem.

Discover emerging opportunities with in-depth research reports:

Oligonucleotide Synthesis Market Size

Oligonucleotide Synthesis Market Share

Oligonucleotide Synthesis Market Trends

Nurse Call System Market Growth

Nurse Call System Market Demand